Paenibacillus strain, antifungal compounds, and methods for their use

US10499656B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10499656-B2
Application numberUS-201816190556-A
CountryUS
Kind codeB2
Filing dateNov 14, 2018
Priority dateMar 26, 2015
Publication dateDec 10, 2019
Grant dateDec 10, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The present invention also provides a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain or a cell-free extract thereof comprising at least one Paeniserine and at least one Paeniprolixin. Also provided are isolated compounds and methods of treating a plant to control a plant disease with the disclosed compositions and compounds.

First claim

Opening claim text (preview).

We claim: 1. A composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module (FusA-A3) or a cell-free extract thereof, wherein the lack of a functional FusA-A3 inhibits synthesis of fusaricidins with a tyrosine or a phenylalanine at amino acid residue (3) compared to synthesis of fusaricidins by a Paenibacillus sp. strain comprising a wild-type fusaricidin synthetase; and wherein the variant fusaricidin synthetase comprises a deletion in FusA-A3 of amino acid residues that correspond to positions Asp254, Ala255, Ser258, Thr297, Leu318, Ala320, Gly341, Val349 and Cys350 of SEQ ID NO: 1 or Asp254, Ala255, Ser258, Thr297, Leu318, Ala320, Ala341, Val349 and Cys350 of SEQ ID NO: 9. 2. The composition of claim 1 , comprising a cell-free extract of the biologically pure culture of the fungicidal Paenibacillus sp. strain. 3. The composition of claim 2 , further comprising at least one Paeniserine and at least one Paeniprolixin. 4. The composition of claim 3 , wherein the at least one Paeniserine is selected from the group consisting of Paeniserine A1, Paeniserine A2, Paeniserine A3, Paeniserine A4, Paeniserine B1, Paeniserine B2, Paeniserine B3, Paeniserine B4, Paeniserine C1, Paeniserine C2, and Paeniserine C3. 5. The composition of claim 3 , wherein the at least one Paeniprolixin is selected from the group consisting of Paeniprolixin A1, Paeniprolixin A2, Paeniprolixin B Paeniprolixin B2, Paeniprolixin C1, Paeniprolixin D1, Paeniprolixin E1, Paeniprolixin E2, Paeniprolixin F1, Paeniprolixin F2, Paeniprolixin G1, and Paeniprolixin G2. 6. The composition of claim 1 comprising a fermentation product of the biologically pure culture of the fungicidal Paenibacillus sp. strain. 7. The composition of claim 6 , wherein the fermentation product is a solid formulation. 8. The composition of claim 6 , wherein the fermentation product is a liquid formulation. 9. The composition of claim 8 comprising at least about 1×10 4 CFU of the strain/mL of the liquid formulation. 10. A method of treating a plant to control a disease, wherein the method comprises applying an effective amount of the composition of claim 1 to the plant, to a part of the plant and/or to a locus of the plant. 11. The method of claim 10 , wherein the composition further comprises at least one Paeniserine and at least one Paeniprolixin. 12. The method of claim 10 , wherein the method comprises applying the composition to foliar plant parts. 13. The method of claim 10 , wherein the composition is applied at about 1×10 10 to about 1×10 12 colony forming units (CFU) of the fungicidal Paenibacillus sp. strain per hectare. 14. The method of claim 10 , wherein the composition is applied at about 0.5 kg to about 5 kg fermentation solids per hectare. 15. The method of claim 10 , wherein the plant disease is caused by a fungus. 16. The method of claim 15 , wherein the plant disease is mildew or a rust disease. 17. The method of claim 16 , wherein the mildew is powdery mildew or downy mildew. 18. The method of claim 16 , wherein the rust disease is selected from the group consisting of wheat leaf rust, leaf rust of barley, leaf rust of rye, brown leaf rust, crown rust, and stem rust. 19. The method of claim 15 , wherein the fungus is selected from the group consisting of Alternaria alternata, Alternaria solani, Botrytis cinerea, Colletotrichum lagenarium, Fusarium culmorum, Phaeosphaeria nodorum, Zymoseptoria tritici, Phytophthora cryptogea, Phytophthora infestans, Pythium ultimum, Magnaporthe oryzae, Thanatephorus cucumeris, Ustilago segetum var. avenae, Uromyces appendiculatus , and Puccinia triticina.

Assignees

Inventors

Classifications

  • from bacteria · CPC title

  • Isomerases (5.) · CPC title

  • Guanidine; Derivatives thereof · CPC title

  • C12N1/20Primary

    Bacteria; Culture media therefor · CPC title

  • having 5 to 11 amino acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10499656B2 cover?
The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The present invention also provides a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain or a cell-free extract thereof …
Who is the assignee on this patent?
Bayer Cropscience Lp
What technology area does this patent fall under?
Primary CPC classification C12N1/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).